Recently, our group also demonstrated that IL-17/IL-17R axis drives intestinal neutrophil migration, limits gut dysbiosis, and attenuates LPS translocation to VAT, protecting against metabolic syndrome (42). The gene discussed is IL17A; the disease is metabolic syndrome.